Hong C I, An S H, Buchheit D J, Nechaev A, Kirisits A J, West C R, Berdel W E
J Med Chem. 1986 Oct;29(10):2038-44. doi: 10.1021/jm00160a041.
Three new 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids (alkyl glycerols) linked by a pyrophosphate diester bond have been prepared and evaluated against mouse leukemia L1210 and P388. These include ara-CDP-rac-1-O-hexadecyl-2-O-palmitoylglycerol (9a) (ara-CDP = 1-beta-D-arabinofuranosylcytosine 5'-diphosphate), ara-CDP-rac-1-O-octadecyl-2-O-palmitoylglycerol (9b), and ara-CDP-rac-1-O-octadecyl-2-O-methylglycerol (9c). Among them, conjugate 9a produced significant increase in life span (200-293%) in mice bearing ip and ic implanted L1210 lymphoic leukemia at a total dose of 400-500 mg (406-508 mumol/kg). Significant schedule dependence was not observed when the conjugate was given ip once daily on day 1, days 1, 5, and 9, and days 1-5. The new conjugates are water soluble by sonication.
已经制备了三种通过焦磷酸二酯键连接的醚脂(烷基甘油)的新型1-β-D-阿拉伯呋喃糖基胞嘧啶共轭物,并针对小鼠白血病L1210和P388进行了评估。这些包括阿糖胞苷二磷酸-外消旋-1-O-十六烷基-2-O-棕榈酰甘油(9a)(阿糖胞苷二磷酸=1-β-D-阿拉伯呋喃糖基胞嘧啶5'-二磷酸)、阿糖胞苷二磷酸-外消旋-1-O-十八烷基-2-O-棕榈酰甘油(9b)和阿糖胞苷二磷酸-外消旋-1-O-十八烷基-2-O-甲基甘油(9c)。其中,共轭物9a在总剂量为400-500mg(406-508μmol/kg)时,使腹腔注射和脑内植入L1210淋巴细胞白血病的小鼠的寿命显著延长(200-293%)。当共轭物在第1天、第1、5和9天以及第1-5天每天腹腔注射一次时,未观察到明显的给药方案依赖性。这些新型共轭物通过超声处理可溶于水。